BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15833784)

  • 1. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
    Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
    Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
    [No Abstract]   [Full Text] [Related]  

  • 2. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
    Adams PC; Reboussin DM; Press RD; Barton JC; Acton RT; Moses GC; Leiendecker-Foster C; McLaren GD; Dawkins FW; Gordeuk VR; Lovato L; Eckfeldt JH
    Am J Med; 2007 Nov; 120(11):999.e1-7. PubMed ID: 17976429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A; Speechley M; Adams PC
    Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemochromatosis mutations in the general population: iron overload progression rate.
    Andersen RV; Tybjaerg-Hansen A; Appleyard M; Birgens H; Nordestgaard BG
    Blood; 2004 Apr; 103(8):2914-9. PubMed ID: 15070663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
    McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM
    Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
    Saliou P; Le Gac G; Mérour MC; Tripogney C; Chanu B; Gourlaouen I; Nousbaum JB; Férec C; Scotet V
    Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
    [No Abstract]   [Full Text] [Related]  

  • 13. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; Eckfeldt JH; McLaren CE; Reiss JA; McLaren GD; Reboussin DM; Gordeuk VR; Speechley MR; Press RD; Dawkins FW;
    Am J Hematol; 2008 Feb; 83(2):126-32. PubMed ID: 17726683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
    Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
    Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
    Harrison HF; Harrison BW; Walker AP; Lohman K; Ellis SD; Hall MA; Reiss J; Adams PC; Holup J; Acton RT; Bent T; Rivers C; Fadojutimi-Akinsiku M
    Genet Test; 2008 Dec; 12(4):491-500. PubMed ID: 18939938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.